Home›Companies›Healthcare›Corista

Corista, LLC

Corista sells pathology image management software to healthcare and life sciences organizations.

Updated Nov 10, 2026·Latest SEC filing Jun 25, 2026·Suggest an edit

About Corista

Corista is a private company based in Concord, Massachusetts. It has reported $13,215,679 raised in two offerings on Form D since December 2025. Its chief executive is Richard Wingard.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jun 17, 2026Jun 25, 2026$50,000of $10.0M target1$50,000EquityRule 506(b)Form D ↗
Mar 1, 2023Dec 3, 2025$13,165,679of $20.0M target77$170KEquityRule 506(b)Form D ↗
Total, two offerings$13,215,679

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Corista's Form D filed Jun 25, 2026.

Elizabeth Wingard
Elizabeth Wingard
Founder & Board Co-Chair
LH
Wayne Butler
Wayne Butler
Chief Commercial Officer & Executive Vice President
Richard Wingard
Richard Wingard
Founder & CEO, director
CW
Conner Wingard
Executive officer
CS
Carolyn Sykes
Executive officer
David Wilbur
David Wilbur
Chief Scientific Officer & Pathologist, director

Earlier filings also listed Keith Kaplan (executive officer, last listed Dec 2025) and J. Barrett (executive officer, last listed Dec 2025).

Sources

  1. SECCorista, LLC filing history
  2. CompanyAbout Corista